Term
|
Definition
|
|
Term
|
Definition
| Asthma, exercise induced asthma; prophylaxis |
|
|
Term
|
Definition
| Tachyarrhythmia, hypokalemia, nausea, pharyngitis, throat irritation, feeling nervous, headache, tremor, cough, URI |
|
|
Term
|
Definition
| Inhalation: metered-dose inhaler, nebulizer, & PO extended release tablets |
|
|
Term
|
Definition
-Proper technique of inhalation
-reduction in asthma symptoms
-pulmonary function tests |
|
|
Term
|
Definition
-anticholinergic
-Bronchodilator
-Nasal Agent |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Abnormal taste (bitter) in mouth, xerostomia, bronchitis, nasal mucosa dry, sinusitis |
|
|
Term
|
Definition
-inhalation
-nebulization
-oral
-nasal spray |
|
|
Term
|
Definition
-asthma: proper technique
-inhalation: reduction in asthma symptoms |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Peripheral edema, pruritus, rash, sweating, abd pain, constipation, diarrhea, loss of appetite, N&V, xerostomia, abnormal liver function tests |
|
|
Term
|
Definition
-enteral route (16 french gastrostomy tube)
-epidural
-intrathecal
-IV
-Oral |
|
|
Term
|
Definition
-pain reduction
-mental & respiratory status
-bowel movements
-signs and symptoms of withdrawal
-BP |
|
|
Term
Fuerosemide (lasix)
drug class |
|
Definition
| Loop diuretic, cardiovascular agent |
|
|
Term
Fuerosemide (lasix)
indications |
|
Definition
| CHF-edema, hypertension, acute pulmonary edema |
|
|
Term
Fuerosemide (lasix)
side effects |
|
Definition
| Hyperuricemia, hypomagnesemia, loss of appetite, spasm of bladder |
|
|
Term
Fuerosemide (lasix)
administration |
|
Definition
|
|
Term
Fuerosemide (lasix)
monitor |
|
Definition
| BP, improvement in edema, serum electrolytes (especially K) |
|
|
Term
|
Definition
| Analgesic, antihistamine, respiratory agent, |
|
|
Term
|
Definition
| Allergic rhinitis, anaphylaxis, common cold, insomnia, motion sickness, parkinsonism, pruritus of skin |
|
|
Term
|
Definition
| Xerostomia, dizziness, dyskinesia, sedated, somnolence, nasal mucosa dry, pharyngeal dryness |
|
|
Term
|
Definition
-(IV, IM) for IV or IM administration only
-IM: administer by deep IM injection
-IV (no more than 25mg/min)
-Oral: don’t break |
|
|
Term
|
Definition
| Allergy: decreased rhinitis, urticarial, itchiness |
|
|
Term
|
Definition
| Anti-inflammatory, leukotriene pathway inhibitor |
|
|
Term
|
Definition
| Asthma, exercise induced asthma, perennial allergic rhinitis, seasonal allergic rhinitis |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Improvements in asthma, blood and liver function tests, potential change in behavior/mood |
|
|
Term
|
Definition
-bronchodilator
-beta-2 adrenergic agonist |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Palpitations, tacyarrhythmia, headache, seizure, tremor, feeling nervous |
|
|
Term
Terbutaline
administration |
|
Definition
-SubQ: administer into the lateral deltoid area
-Do NOT administer as IV infusion |
|
|
Term
|
Definition
Reduced asthma symptoms, & pulmonary function tests
ECG, BP, HR (for pts with cardiac hx) |
|
|
Term
|
Definition
-Adrenal glucocorticoid
-endocrine-metabolic agent |
|
|
Term
|
Definition
| respiratory system disorder |
|
|
Term
|
Definition
| Hypertension, atrophic condition of skin, finding of skin healing impaired, body fluid retention, decreased body growth, hypernatremia, disorder of GI tract, at risk for infection, osteoporosis, depression, euphoria |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Clinical improvement, BP, electrolyte panel, blood glucose, mental status, ophthalmic exam (w/prolonged therapy), signs and symptoms of infection, hypothalamic pituitary adrenal axis suppression. |
|
|
Term
|
Definition
-Adrenal glucocorticoid
-anti-inflammatory, corticosteroid |
|
|
Term
|
Definition
| Allergic rhinitis, asthma, atopic dermatitis, disorder of skin, nonallergic rhinitis |
|
|
Term
|
Definition
| Candidiasis of mouth and esophagus, headache, bronchitis, cough, epistaxis, inflammatory disorder of upper respiratory tract, throat irritation, URI |
|
|
Term
|
Definition
-Inhalation: shake inhaler well, rinse mouth with water and spit after inhalation, never wash mouth piece
-Nasal: shake gently before use
-topical: apply thin layer, do not use occlusive dressing, do not use on face, underarms, or groin |
|
|
Term
|
Definition
Asthma: proper technique with inhaled agents.
signs/symptoms of systemic corticosteroid effects
long term therapy: bone density, ophthalmologic exam |
|
|
Term
|
Definition
Antiasthma
Anti-inflammatory/ bronchodilator combination |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Nausea, oral candidiasis, musculoskeletal pain, dizziness, headache, bronchitis, cough, difficulty speaking, hoarse, pharyngitis, throat irritation, URI, viral lower respiratory infection |
|
|
Term
|
Definition
Inhalation: shake inhaler for 5 seconds before each use, discard inhaler after 120 uses.
Powder & aerosol: rinse mouth w/water and spit after use |
|
|
Term
|
Definition
| Proper technique of inhalation, pulmonary function tests, control or improvement of asthma or COPD, bone mineral density, toxicity |
|
|
Term
|
Definition
| Adrenal glucocorticoid, anti-inflammatory, endocrine-metabolic agent |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Diarrhea, nausea, arthralgia, headache, epistaxis, nasal stinging/burning, respiratory tract infection, sinusitis |
|
|
Term
|
Definition
Inhalation: do not shake inhaler, after inhalation (rinse mouth with water and spit)
Nasal: shake gently before use
Oral: swallow capsule whole, take capsule in the morning |
|
|
Term
|
Definition
Asthma: reduced symptoms & improved pulmonary function tests
Signs and symptoms of hypercorticism, increased; in pts with moderate to severe liver disease |
|
|
Term
|
Definition
-Antiasthma
-Mast cell stabilizer |
|
|
Term
|
Definition
| Allergic rhinitis, asthma, keratitis, systemic mast cell disease, |
|
|
Term
|
Definition
| Bad taste in mouth, burning sensation in eye, cough, throat irritation |
|
|
Term
|
Definition
Inhalation: shake canister
Ophthalmic: avoid contact lenses during treatment
Oral: empty ampule into glass of water and drink 30 minutes before meals and at |
|
|
Term
|
Definition
Bronchial asthma: pulmonary function tests, symptomatic improvement
Ophthalmic: eye exam |
|
|
Term
|
Definition
-diagnostic agent, bronchial
-mucolytic |
|
|
Term
|
Definition
| asthmatic bronchitis (chronic), atelectasis due to mucous obstruction, bronchopulmonary disease, cystic fibrosis (pulmonary), dx procedure on lower respiratory tract, tracheostomy care |
|
|
Term
|
Definition
| Pruritus, urticarial, diarrhea, N&V |
|
|
Term
|
Definition
| Inhalation: may be administered through nebulization into face mask, mouth piece, tracheostomy, tent, or croupette, or through direct instillation intratracheally |
|
|
Term
|
Definition
Mucolytic agent: decreased mucous viscosity, a productive cough, improvements in respirations
IV: serious anaphylactoid reaction, especially during the 1st 30-60 min
IV: acute flushing and erythema; particularly during administration of loading dose |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Guaifenesin
administrations |
|
Definition
Oral: do not crush, chew, or break tablet.
Take with a full glass of water
Take with or without food |
|
|
Term
|
Definition
| Reduced cough, cough productivity |
|
|
Term
|
Definition
-Antitubercular
-rifamycin |
|
|
Term
|
Definition
| Acive TB, active TB with active HIV, HIV infection with inactive TB, inactive TB, meningitis, reactivation TB |
|
|
Term
|
Definition
| Agranulocytosis, disseminated intravascular coagulation, hepatitis, hepatotoxicity, anaphylaxis, nephrotoxicity, renal failure |
|
|
Term
|
Definition
IV: reconsistute with 10mL sterile water for injection and gently swirl vial. Should NOT be given IM or SubQ
Oral: take 1 hr before or 2 hr after meal with a full glass of water |
|
|
Term
|
Definition
Pulmonary TB: serial acid fast bacillis sputum cultures, chest xray
TB: cultures, normalization of WBC count, liver function tests, bilirubin levels, serum creatinine & CBC panel |
|
|
Term
|
Definition
-antitubercular
-isonicotinic acid |
|
|
Term
|
Definition
| Active TB, active TB – HIV infection, HIV infection – inactive TB, inactive TB |
|
|
Term
|
Definition
| Increased liver enzymes, neuropathy neurotoxicity |
|
|
Term
|
Definition
| Oral: take on an empty stomach |
|
|
Term
|
Definition
| Chest xray, sputum, symptomatic improvement, direct observation of compliance, hepatic enzymes, signs and symptoms of liver toxicity |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Anticoagulant therapy, transfusion blood product, afib, disseminated intravascular coagulation, heart operation, pulmonary embolism, thrombosis, venous catheter occlusion |
|
|
Term
|
Definition
| Thrombocytopenia, increased liver aminotransferase level |
|
|
Term
|
Definition
General info: administer only by intermittent IV injection, IV infusion, or deep subq injection, avoid IM injection
IV: invert infusion solutions at least 6 times to preven pooling
SubQ: inject deep subq |
|
|
Term
|
Definition
| Coagulation tests for dosage adjustments, hematocrit, platelet counts, stool occult blood tests, signs/symptoms of hemorrhage, signs/symptoms of thrombosis |
|
|
Term
|
Definition
|
|
Term
|
Definition
| pulmonary embolism, thrombosis, venous thromboembolism |
|
|
Term
|
Definition
No common SE just serious:
Cholesterol embolus syndrome, tissue necrosis, hemorrhage, hypersensitivity reaction, intraocular hemorrhage |
|
|
Term
|
Definition
General info: injection for IV use only, not recommended for IM administration
IV: reconstitute 5 mg vial with 2.7 mL sterile water for injection, administer as slow bolus injection over 1-2 min into |
|
|
Term
|
Definition
INR: daily following the initial dose until the INR stabilized to the therapeutic range.
Monitor INR
Signs and symptoms of necrosis and/or gangrene of skin and other tissues |
|
|
Term
|
Definition
Anticoagulant
Low molecular weight heparin |
|
|
Term
|
Definition
| Abd surgery – post op deep vein thrombosis, deep venous thrombosis |
|
|
Term
|
Definition
| Diarrhea, nausea, anemia, major bleeding, thrombocytopenia, increased liver function test, fever |
|
|
Term
|
Definition
General: do not administer by IM injection
Intravenous: compatible with D5W or NS, flush IV line with sufficient quantity of D5W or NS before and after bolus administration to avoid mixing with other drugs
Subq: prefilled syringes, do not expel air bubble from syringe prior to injection, administer by deep subq with pt lying down, do not rub injection site |
|
|
Term
|
Definition
| CBC, liver function tests, BP, plasma anti-factor Xa in pts with significant renal impairments |
|
|
